Novavax is a πππ-Elsa sings, "Let it go,let it go, can't hold it back anymore πππ" $Novavax(NVAX)$
NVAX has been a heartache to a lot of investors πππ It tumbled from its all-time high of USD 319.93 on Feb 8, 2021, which is a about an 88% CRASH π±π±π±
NVAX has repeatedly pushed back production forecasts & has struggled to access raw materials & equipment needed to make its vaccine ππ π
Till nowβ¦NVAX still hasnβt obtained full FDA approval for its vaccine β It was only granted Emergency Use Authorisation for over 18 year-olds in early June & WHO has not recognised their vaccine use for below 18 years of age β
Now, it has even:
(1) posted a 3rd quarter loss of 6.53 per share, with revenues slowing 37.6% from last year to just 185.9 million;
(2) halved its 2022 sales forecast to between $2 billion and $2.3 billion; &
(3) warned that it does not expect to sell any more of its Covid vaccines in the US this year.
π€π: My Thoughts: This earnings is too BIG a miss & it sure shows how the management of NVAX over-promises & under-delivers. Their historical trend shows this as well (see photo). A successful company requires great leaders & direction-this is something that NVAX doesnβt have & will not be able to compete with Pfizer-BioNTech or Moderna. I donβt have a target price for NVAX as I really can't see it as a profitable companyβ¦Sorry π―π―π―
As usual-π€π Consider POV & Actions of investors + π©π»βπ»π¨π»βπ» Research + πFOMO & Greed = Investing Wisely π€π€ + Accumulating Wealth π΅π°
@TigerStars@CaptainTiger@MillionaireTiger
Comments
1.Pfizer,...
2. binoma
3. clover...
4 .......
lot more to name.....